Inventor · disambiguated record
Stephen Kelsey
Also filed as: KELSEY STEPHEN · KELSEY STEPHEN M · KELSEY STEPHEN MICHAEL
5 granted patents·22 pending applications·97 citations·filing 2003–2024
80Inventor score
Top patents by PatentIndex Score
27 records- 0192US8163287B2Combination therapy of her expressing tumorsSLIWKOWSKI MARK X·Filed 2006·Granted Apr 24, 2012·47 cites·45 claims
- 0289US8691232B2Extending time to disease progression or survival in cancer patientsDERYNCK MIKA K·Filed 2011·Granted Apr 8, 2014·42 cites·34 claims
- 0387US9375485B2Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasmsGERON CORP·Filed 2013·Granted Jun 28, 2016·8 cites·53 claims
- 0486US12442000B2Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasmsGERON CORP·Filed 2024·Granted Oct 14, 2025·0 cites·10 claims
- 0573US2023183704A1Use of Telomerase Inhibitors for the Treatment of Myeloproliferative Disorders and Myeloproliferative NeoplasmsGERON CORP·Filed 2022·Application pending·0 cites
- 0673US2025090532A1Shp2 inhibitor compositions and methods for treating cancerREVOLUTION MEDICINES INC·Filed 2024·Application pending·0 cites
- 0769US2024058341A1SHP2 Inhibitor Compositions and Methods for Treating CancerREVOLUTION MEDICINES INC·Filed 2023·Application pending·0 cites
- 0862US2009155259A1Extending time to disease progression or survival in cancer patientsGENENTECH INC·Filed 2008·Application pending·0 cites
- 0960US2020102564A1Use of Telomerase Inhibitors for the Treatment of Myeloproliferative Disorders and Myeloproliferative NeoplasmsGERON CORP·Filed 2018·Application pending·0 cites
- 1059US2017051287A1Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasmsGERON CORP·Filed 2016·Application pending·0 cites
- 1158US11596633B2SHP2 inhibitor compositions and methods for treating cancerREVOLUTION MEDICINES INC·Filed 2020·Granted Mar 7, 2023·0 cites·21 claims
- 1258US2014186347A1Extending time to disease progression or survival in cancer patientsGENENTECH INC·Filed 2014·Application pending·0 cites
- 1358US2015086545A1Combination therapy of her expressing tumorsGENENTECH INC·Filed 2014·Application pending·0 cites
- 1457US2004106161A1Methods for identifying tumors that are responsive to treatment with anti-ErbB2 antibodiesFiled 2003·Application pending·0 cites
- 1557US2018236072A1Extending time to disease progression or survival in cancer patientsGENENTECH INC·Filed 2017·Application pending·0 cites
- 1655US2006188509A1Extending time to disease progression or survival in cancer patientsGENENTECH INC·Filed 2006·Application pending·0 cites
- 1754US2007269429A1Treatment with anti-erbb2 antibodiesGENENTECH INC·Filed 2007·Application pending·0 cites
- 1851US2015273059A1Extending time to disease progression or survival in cancer patientsGENENTECH INC·Filed 2015·Application pending·0 cites
- 1949US2012251530A1Combination therapy of her expressing tumorsSLIWKOWSKI MARK X·Filed 2012·Application pending·0 cites
- 2049US2004013667A1Treatment with anti-ErbB2 antibodiesGENENTECH INC·Filed 2003·Application pending·0 cites
- 2147US2006013819A1Therapy of platinum-resistant cancerGENENTECH INC·Filed 2005·Application pending·0 cites
- 2246US2011117096A1Methods for Identifying Tumors That are Responsive to Treatement With Anti-ErbB2 AntibodiesBOSSENMAIER BIRGIT·Filed 2010·Application pending·0 cites
- 2343US2012107391A1Therapy of platinum-resistant cancerKELSEY STEPHEN M·Filed 2011·Application pending·0 cites
- 2442US2015342982A1Use of Telomerase Inhibitors for the Treatment of Myeloproliferative Disorders and Myeloproliferative NeoplasmsGERON CORP·Filed 2013·Application pending·0 cites
- 2540US2021206818A1Messenger ribonucleic acids for the production of intracellular binding polypeptides and methods of use thereofMODERNATX INC·Filed 2017·Application pending·0 cites
- 2639US2005182122A1Method of treating abnormal cell growth using indolinone compoundsFiled 2004·Application pending·0 cites
- 2734US2019119357A1Messenger ribonucleic acids for the production of intracellular binding polypeptides and methods of use thereofMODERNATX INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stephen Kelsey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →